SINGH SHAWN (CHIEF EXECUTIVE OFFICER) exercised options at VISTAGEN THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 4/27/2021ACC: 0001415889-21-002139
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Aug 2018
0.00
Net shares
Net seller
$7.5K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
5K acquired · 5K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$1.50
Trade value
$7.50K
% of position
14.1%
4/23/2021
35.38K→40.38K
Total
Net shares
+5K
Net value
$7.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/23/2021 | M · Option Exercise | +5K | $1.50 | $7.50K | 14.1% | 35.38K | 40.38K |
| Total | +5K | $7.50K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
1.50
Held after
0.00
Exercisable
—
4/23/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5K shares | 4/23/2021 | M · Option Exercise | −5K | 1.50 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned26.23K
Total
26.23K indirect26.23K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 26.23K | Indirect |
| Total | 26.23K | 26.23K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported